Insmed is a research-driven biopharmaceutical company based in Richmond, Virginia and Boulder, Colorado.
Insmed is a research-driven biopharmaceutical company based in Richmond, Virginia and Boulder, Colorado. Insmed's goal is to be one of the first U.S.-based biotechnology companies to develop a comprehensive portfolio of follow-on biologics. Members of Insmed's skilled biologics team have worked on over 50 therapeutic proteins. Their focused scientific background coupled with our sate of the art protein manufacturing capability, protein characterization and clinical and regulatory expertise positions Insmed to be a leading company in the entry of the U.S. market with a broad range of follow on biologics when the patents covering the innovator products expire. Follow-on biologics are versions of approved biologics that are developed after the original product has been created with the intention of marketing them after the patent on the innovator product has expired, thus bringing competition to monopolistic markets.